
### [MONDO:0019351](http://purl.obolibrary.org/obo/MONDO_0019351)
**Label:** isolated spina bifida

**Subclasses:** [MONDO:0017068](http://purl.obolibrary.org/obo/MONDO_0017068) (upper thoracic spina bifida aperta), [MONDO:0017067](http://purl.obolibrary.org/obo/MONDO_0017067) (Cervicothoracic spina bifida aperta), [MONDO:0019773](http://purl.obolibrary.org/obo/MONDO_0019773) (myelomeningocele), [MONDO:0011120](http://purl.obolibrary.org/obo/MONDO_0011120) (neural tube defects, folate-Sensitive), [MONDO:0017069](http://purl.obolibrary.org/obo/MONDO_0017069) (spina bifida cystica), [MONDO:0017075](http://purl.obolibrary.org/obo/MONDO_0017075) (upper thoracic spina bifida cystica), [MONDO:0017064](http://purl.obolibrary.org/obo/MONDO_0017064) (Thoracolumbosacral spina bifida aperta), [MONDO:0017074](http://purl.obolibrary.org/obo/MONDO_0017074) (Cervicothoracic spina bifida cystica), [MONDO:0017063](http://purl.obolibrary.org/obo/MONDO_0017063) (total spina bifida aperta), [MONDO:0017066](http://purl.obolibrary.org/obo/MONDO_0017066) (cervical spina bifida aperta), [MONDO:0017077](http://purl.obolibrary.org/obo/MONDO_0017077) (Myelocystocele), [MONDO:0017065](http://purl.obolibrary.org/obo/MONDO_0017065) (lumbosacral spina bifida aperta), [MONDO:0017076](http://purl.obolibrary.org/obo/MONDO_0017076) (posterior meningocele), [MONDO:0017071](http://purl.obolibrary.org/obo/MONDO_0017071) (Thoracolumbosacral spina bifida cystica), [MONDO:0017070](http://purl.obolibrary.org/obo/MONDO_0017070) (total spina bifida cystica), [MONDO:0017062](http://purl.obolibrary.org/obo/MONDO_0017062) (spina bifida aperta), [MONDO:0017073](http://purl.obolibrary.org/obo/MONDO_0017073) (cervical spina bifida cystica), [MONDO:0017072](http://purl.obolibrary.org/obo/MONDO_0017072) (lumbosacral spina bifida cystica), [MONDO:0008816](http://purl.obolibrary.org/obo/MONDO_0008816) (Arnold-Chiari malformation type II), [MONDO:0010525](http://purl.obolibrary.org/obo/MONDO_0010525) (neural tube defects, X-linked), 

**Mapped go classes:** [GO:0016723](http://purl.obolibrary.org/obo/GO_0016723) (oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0006164](http://purl.obolibrary.org/obo/GO_0006164) (purine nucleotide biosynthetic process), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0046655](http://purl.obolibrary.org/obo/GO_0046655) (folic acid metabolic process), [GO:0046656](http://purl.obolibrary.org/obo/GO_0046656) (folic acid biosynthetic process), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0009235](http://purl.obolibrary.org/obo/GO_0009235) (cobalamin metabolic process), [GO:0009113](http://purl.obolibrary.org/obo/GO_0009113) (purine nucleobase biosynthetic process), [GO:0006760](http://purl.obolibrary.org/obo/GO_0006760) (folic acid-containing compound metabolic process), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process), [GO:0072341](http://purl.obolibrary.org/obo/GO_0072341) (modified amino acid binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0070402](http://purl.obolibrary.org/obo/GO_0070402) (NADPH binding), [GO:0035999](http://purl.obolibrary.org/obo/GO_0035999) (tetrahydrofolate interconversion), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0009070](http://purl.obolibrary.org/obo/GO_0009070) (serine family amino acid biosynthetic process), [GO:0030586](http://purl.obolibrary.org/obo/GO_0030586) ([methionine synthase] reductase activity), [GO:0009086](http://purl.obolibrary.org/obo/GO_0009086) (methionine biosynthetic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0000105](http://purl.obolibrary.org/obo/GO_0000105) (histidine biosynthetic process), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:0004477](http://purl.obolibrary.org/obo/GO_0004477) (methenyltetrahydrofolate cyclohydrolase activity), [GO:0008705](http://purl.obolibrary.org/obo/GO_0008705) (methionine synthase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0050444](http://purl.obolibrary.org/obo/GO_0050444) (aquacobalamin reductase (NADPH) activity), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0031060](http://purl.obolibrary.org/obo/GO_0031060) (regulation of histone methylation), [GO:0042558](http://purl.obolibrary.org/obo/GO_0042558) (pteridine-containing compound metabolic process), [GO:0070829](http://purl.obolibrary.org/obo/GO_0070829) (heterochromatin maintenance), [GO:0009257](http://purl.obolibrary.org/obo/GO_0009257) (10-formyltetrahydrofolate biosynthetic process), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0004487](http://purl.obolibrary.org/obo/GO_0004487) (methylenetetrahydrofolate dehydrogenase (NAD+) activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0004489](http://purl.obolibrary.org/obo/GO_0004489) (methylenetetrahydrofolate reductase (NAD(P)H) activity), [GO:0004488](http://purl.obolibrary.org/obo/GO_0004488) (methylenetetrahydrofolate dehydrogenase (NADP+) activity), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding), [GO:0019346](http://purl.obolibrary.org/obo/GO_0019346) (transsulfuration), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:1904042](http://purl.obolibrary.org/obo/GO_1904042) (negative regulation of cystathionine beta-synthase activity), [GO:0043418](http://purl.obolibrary.org/obo/GO_0043418) (homocysteine catabolic process), [GO:0033353](http://purl.obolibrary.org/obo/GO_0033353) (S-adenosylmethionine cycle), [GO:0008652](http://purl.obolibrary.org/obo/GO_0008652) (cellular amino acid biosynthetic process), [GO:0047138](http://purl.obolibrary.org/obo/GO_0047138) (aquacobalamin reductase activity), [GO:0009069](http://purl.obolibrary.org/obo/GO_0009069) (serine family amino acid metabolic process), [GO:0001780](http://purl.obolibrary.org/obo/GO_0001780) (neutrophil homeostasis), [GO:0006479](http://purl.obolibrary.org/obo/GO_0006479) (protein methylation), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0006306](http://purl.obolibrary.org/obo/GO_0006306) (DNA methylation), [GO:0004329](http://purl.obolibrary.org/obo/GO_0004329) (formate-tetrahydrofolate ligase activity), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0003958](http://purl.obolibrary.org/obo/GO_0003958) (NADPH-hemoprotein reductase activity), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0050667](http://purl.obolibrary.org/obo/GO_0050667) (homocysteine metabolic process), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.56%
- [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding) 51.61%
- [GO:0070402](http://purl.obolibrary.org/obo/GO_0070402) (NADPH binding) 51.61%
- [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding) 51.61%
- [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding) 51.61%
- [GO:0050444](http://purl.obolibrary.org/obo/GO_0050444) (aquacobalamin reductase (NADPH) activity) 51.61%
- [GO:0047138](http://purl.obolibrary.org/obo/GO_0047138) (aquacobalamin reductase activity) 51.61%
- [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding) 51.61%
- [GO:0030586](http://purl.obolibrary.org/obo/GO_0030586) ([methionine synthase] reductase activity) 51.61%
- [GO:0016653](http://purl.obolibrary.org/obo/GO_0016653) (oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor) 51.61%
- [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding) 51.61%
- [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding) 51.61%
- [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding) 51.61%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 51.61%
- [GO:0004489](http://purl.obolibrary.org/obo/GO_0004489) (methylenetetrahydrofolate reductase (NAD(P)H) activity) 51.61%


